Signaling Pathways - RSK - PP2A/Nkd interaction - c-MET - CCL2
清除全部
- B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂
- B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂
- B7700 IQ 1Target: Stem Cell Differentiation|PP2A/Nkd interactionSummary: 维持胚胎干细胞(ESC)的多能性
- B3392 GSK269962ATarget: ROCK|RSK|MSKSummary: ROCK抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8448 INCB28060中文名: 苯扎米特Target: c-METSummary: C-Met抑制剂
- A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂
- A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂
- A5096 PF-04217903Target: c-METSummary: C-Met的选择性和ATP竞争性抑制剂
- A2307 PHA-6657521 CitationTarget: c-METSummary: c-Met的ATP竞争性、有效的、选择性抑制剂